Endocrine Disruptome - An Open Source Prediction Tool for Assessing Endocrine Disruption Potential through Nuclear Receptor Binding

Predicting the endocrine disruption potential of compounds is a daunting but essential task. Here we report a new tool for this purpose that we have termed Endocrine Disruptome. It is a free and simple-to-use Web service that runs on an open source platform called Docking interface for Target Systems (DoTS). The molecular docking is handled via AutoDock Vina. Compounds are docked to 18 integrated and well-validated crystal structures of 14 different human nuclear receptors: androgen receptor; estrogen receptors α and β; glucocorticoid receptor; liver X receptors α and β; mineralocorticoid receptor; peroxisome proliferator activated receptors α, β/δ, and γ; progesterone receptor; retinoid X receptor α; and thyroid receptors α and β. Endocrine Disruptome is free of charge and available at http://endocrinedisruptome.ki.si.

[1]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[2]  Rajarshi Guha,et al.  KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries , 2011, Molecular informatics.

[3]  M F Sanner,et al.  Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.

[4]  A. Charles,et al.  Oestrogenic and androgenic activity of triclosan in breast cancer cells , 2008, Journal of applied toxicology : JAT.

[5]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[6]  M. Jacobs,et al.  In silico tools to aid risk assessment of endocrine disrupting chemicals. , 2004, Toxicology.

[7]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[8]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[9]  Angelo Vedani,et al.  In Silico Toxicology in Drug Discovery — Concepts Based on Three-dimensional Models , 2009, Alternatives to laboratory animals : ATLA.

[10]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[11]  Ana M Soto,et al.  Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. , 2009, Endocrine reviews.

[12]  Wolfgang Muster,et al.  Computational toxicology in drug development. , 2008, Drug discovery today.

[13]  A. Vedani,et al.  VirtualToxLab - a platform for estimating the toxic potential of drugs, chemicals and natural products. , 2012, Toxicology and applied pharmacology.

[14]  G. Klebe.  Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.

[15]  A. Mathai,et al.  Understanding and using sensitivity, specificity and predictive values , 2008, Indian journal of ophthalmology.

[16]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[17]  D. Altman,et al.  Statistics Notes: Diagnostic tests 2: predictive values , 1994, BMJ.

[18]  Xicheng Wang,et al.  An effective docking strategy for virtual screening based on multi-objective optimization algorithm , 2009, BMC Bioinformatics.

[19]  M. Denison,et al.  In Vitro Biologic Activities of the Antimicrobials Triclocarban, Its Analogs, and Triclosan in Bioassay Screens: Receptor-Based Bioassay Screens , 2008, Environmental health perspectives.

[20]  J. Pin,et al.  Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. , 2005, Journal of medicinal chemistry.

[21]  N. Manabe,et al.  Effects of in utero exposure to bisphenol A on expression of RARalpha and RXRalpha mRNAs in murine embryos. , 2003, The Journal of reproduction and development.

[22]  Tae-Hee Kim,et al.  Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors , 2012, Journal of cellular and molecular medicine.

[23]  C. Sadasivan,et al.  Bisphenol‐A can bind to human glucocorticoid receptor as an agonist: an in silico study , 2010, Journal of applied toxicology : JAT.

[24]  Bruce Blumberg,et al.  Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. , 2006, Endocrinology.

[25]  B. Hammock,et al.  Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. , 2007, Toxicology and applied pharmacology.

[26]  Chris Morley,et al.  Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit , 2008, Chemistry Central journal.

[27]  J. Devillers,et al.  SAR and QSAR modeling of endocrine disruptors , 2006, SAR and QSAR in environmental research.

[28]  Vincent Laudet,et al.  Overview of Nomenclature of Nuclear Receptors , 2006, Pharmacological Reviews.

[29]  Hannu Raunio,et al.  In Silico Toxicology – Non-Testing Methods , 2011, Front. Pharmacol..

[30]  M. Stacewicz‐Sapuntzakis,et al.  Androgenic properties of gibberellic acid in the chick comb bioassay , 1977, Experientia.

[31]  Pierre Crettaz,et al.  Some flame retardants and the antimicrobials triclosan and triclocarban enhance the androgenic activity in vitro. , 2010, Chemosphere.

[32]  M Balls,et al.  Methods of in vitro toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[33]  M. Stacewicz‐Sapuntzakis,et al.  Synergistic uterotrophic effect of gibberellic acid and estradiol in the immature mouse. , 1977, Life sciences.

[34]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[35]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[36]  M. Brady,et al.  Environmental Endocrine Disruptors Promote Adipogenesis in the 3T3‐L1 Cell Line through Glucocorticoid Receptor Activation , 2010, Obesity.

[37]  Alex Odermatt,et al.  Disruption of Glucocorticoid and Mineralocorticoid Receptor-Mediated Responses by Environmental Chemicals , 2008 .

[38]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[39]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[40]  B. Rubin,et al.  Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  Rita Fabbri,et al.  Direct effects of Bisphenol A on lipid homeostasis in rat hepatoma cells. , 2013, Chemosphere.

[42]  Ian A. Watson,et al.  Rules for identifying potentially reactive or promiscuous compounds. , 2012, Journal of medicinal chemistry.

[43]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[44]  J A Swets,et al.  Measuring the accuracy of diagnostic systems. , 1988, Science.